These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 25379678)

  • 1. Risk assessment of component failure modes and human errors using a new FMECA approach: application in the safety analysis of HDR brachytherapy.
    Giardina M; Castiglia F; Tomarchio E
    J Radiol Prot; 2014 Dec; 34(4):891-914. PubMed ID: 25379678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk analysis using fuzzy set theory of the accidental exposure of medical staff during brachytherapy procedures.
    Castiglia F; Giardina M; Tomarchio E
    J Radiol Prot; 2010 Mar; 30(1):49-62. PubMed ID: 20220212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of high-dose-rate brachytherapy accidents. ICRP Publication 97.
    Valentin J;
    Ann ICRP; 2005; 35(2):1-51. PubMed ID: 16243099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel process for introducing a new intraoperative program: a multidisciplinary paradigm for mitigating hazards and improving patient safety.
    Rodriguez-Paz JM; Mark LJ; Herzer KR; Michelson JD; Grogan KL; Herman J; Hunt D; Wardlow L; Armour EP; Pronovost PJ
    Anesth Analg; 2009 Jan; 108(1):202-10. PubMed ID: 19095851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protecting people against radiation exposure in the event of a radiological attack. A report of The International Commission on Radiological Protection.
    Valentin J;
    Ann ICRP; 2005; 35(1):1-110, iii-iv. PubMed ID: 16164984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application of failure mode and effects analysis to intraoperative radiation therapy using mobile electron linear accelerators.
    Ciocca M; Cantone MC; Veronese I; Cattani F; Pedroli G; Molinelli S; Vitolo V; Orecchia R
    Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):e305-11. PubMed ID: 21708432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measurement of dose perturbation around shielded ovoids in high-dose-rate brachytherapy.
    Hira M; Podgorsak MB; Jaggernauth W; Malhotra HK
    Brachytherapy; 2011; 10(3):232-41. PubMed ID: 20932810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ICRP publication 109. Application of the Commission's Recommendations for the protection of people in emergency exposure situations.
    Clarke R; Valentin J;
    Ann ICRP; 2009; 39(1):1-110. PubMed ID: 19853177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Safety in brachytherapy].
    Marcié S; Marinello G; Peiffert D; Lartigau É
    Cancer Radiother; 2013 Apr; 17(2):166-9. PubMed ID: 23465784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Using failure mode effects and criticality analysis for high-risk processes at three community hospitals.
    Coles G; Fuller B; Nordquist K; Kongslie A
    Jt Comm J Qual Patient Saf; 2005 Mar; 31(3):132-40. PubMed ID: 15828596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intraoperative high-dose-rate brachytherapy using dose painting technique: evaluation of safety and preliminary clinical outcomes.
    Morikawa LK; Zelefsky MJ; Cohen GN; Zaider M; Chiu J; Mathur N; Worman MF; Goodman KA
    Brachytherapy; 2013; 12(1):1-7. PubMed ID: 23167979
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FMECA methodology applied to two pathways in an orthopaedic hospital in Milan.
    Morelli P; Vinci A; Galetto L; Magon G; Maniaci V; Banfi G
    J Prev Med Hyg; 2007 Jun; 48(2):54-9. PubMed ID: 17713140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Emergency management in high dose rate afterloading: a topic requiring updates].
    Mühle S
    Strahlenther Onkol; 1999 Oct; 175(10):530-1. PubMed ID: 10554649
    [No Abstract]   [Full Text] [Related]  

  • 14. Quality Assurance with Plan Veto: reincarnation of a record and verify system and its potential value.
    Noel CE; Gutti V; Bosch W; Mutic S; Ford E; Terezakis S; Santanam L
    Int J Radiat Oncol Biol Phys; 2014 Apr; 88(5):1161-6. PubMed ID: 24661669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is ICRP guidance on the use of reference levels consistent?
    Hedemann-Jensen P; McEwan AC
    J Radiol Prot; 2011 Dec; 31(4):431-44. PubMed ID: 22089983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Global nuclear industry views: challenges arising from the evolution of the optimisation principle in radiological protection.
    Saint-Pierre S
    Ann ICRP; 2012; 41(3-4):275-81. PubMed ID: 23089026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiation safety aspects of brachytherapy for prostate cancer using permanently implanted sources. A report of ICRP Publication 98.
    International Commission on Radiological Protection
    Ann ICRP; 2005; 35(3):iii-vi, 3-50. PubMed ID: 16330284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ionizing radiation, part 1: X- and gamma-radiation, and neutrons. Overall introduction.
    IARC Monogr Eval Carcinog Risks Hum; 2000; 75 Pt 1(PT 1):35-115. PubMed ID: 10932818
    [No Abstract]   [Full Text] [Related]  

  • 19. Current issues and actions in radiation protection of patients.
    Holmberg O; Malone J; Rehani M; McLean D; Czarwinski R
    Eur J Radiol; 2010 Oct; 76(1):15-9. PubMed ID: 20638809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravitreal injections: a healthcare failure modes and effects analysis.
    Lanzetta P; Holz F; Monés J; Querques G; Stanga P; Veritti D; Barbone F; Brusaferro S; Isola M
    Ophthalmologica; 2013; 230(3):151-64. PubMed ID: 24008511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.